NOW:53208:USA01012
http://widgets.journalinteractive.com/cache/JIResponseCacher.ashx?duration=5&url=http%3A%2F%2Fdata.wp.myweather.net%2FeWxII%2F%3Fdata%3D*USA01012
12°
H 27° L 12°
Clear | 16MPH

Enzyme Replacement Therapy Shows Promising Results in X-Linked Myotubular Myopathy

Jan. 24, 2013

A collaborative research team including a Medical College of Wisconsin (MCW) pediatric neuropathologist successfully mitigated some of the effects of a muscular disease by using a new targeted enzyme replacement therapy strategy from 4s3 Bioscience.

The findings are published in the January edition of Human and Molecular Genetics http://hmg.oxfordjournals.org/content/early/2013/01/09/hmg.ddt003.full.pdf+html.

X-linked myotubular myopathy (XLMTM) is a severe muscle disease caused by an absence of a protein called myotubularin. There is currently no treatment for this disorder, and most patients die in infancy or childhood. The overall incidence of myotubular myopathy is 1 in 50,000 live male births.

Michael W. Lawlor, MD, PhD, assistant professor of pathology at MCW, researcher at the Children’s Hospital of Wisconsin Research Institute, and director of the pediatric pathology neuromuscular laboratory in MCW’s division of pediatric pathology, coordinated a study at Boston Children’s Hospital and MCW that used targeted enzyme replacement therapy to deliver myotubularin to muscles of mice with XLMTM. After two weeks of treatment, the mice showed marked improvement in muscle function and pathology.

“These promising findings suggest that even low levels of myotubularin protein replacement can not only improve weakness in patients, but also at least partially reverse the structural abnormalities seen in XLMTM,” said Dr. Lawlor. “The next step is to determine appropriate dosage, and toxicity, before we venture into human trials,” he continued.

The study was supported by the National Institutes of Health, the Muscular Dystrophy Association, the Joshua Frase Foundation, and the Lee and Penny Anderson Family Foundation.

Co-authors of the study are Dustin Armstrong and Michael O’Callaghan from 4s3 Bioscience, Inc.; Marissa Viola, Cynthia P. Hsu, and Alan H. Beggs from Boston Children’s Hospital and Harvard Medical School; Jeffrey J. Widrick from Spaulding Rehabilitation Hospital; Hui Meng from MCW; Robert W. Grange from Virginia Tech; Martin Childers from Wake Forest University; Christopher R. Pierson from Nationwide Children’s Hospital; and Anna Buj-Bello from INSERM.

The efforts of Drs. Armstrong, Beggs, and Lawlor began while Dr. Lawlor was working for Dr. Beggs at Boston Children’s Hospital, and this collaborative effort has continued at Dr. Lawlor’s lab at MCW. As studies progress, Dr. Lawlor will continue to perform pathological analyses on research tissue from preclinical studies with the 4s3 Bioscience replacement enzyme and assist in further elucidating the pathophysiology of XLMTM. This work by Dr. Lawlor’s laboratory utilizes resources partially supported and available through the Children’s Research Institute’s Imaging Core Facility.

This site uses Facebook comments to make it easier for you to contribute. If you see a comment you would like to flag for spam or abuse, click the "x" in the upper right of it. By posting, you agree to our Terms of Use.

Suburban News Roundup

E-mail Newsletter

Your link to the biggest stories in the suburbs delivered Thursday mornings.


Enter your e-mail address above and click "Sign Up Now!" to begin receiving your e-mail newsletter
Get the Newsletter!

Login or Register to manage all your newsletter preferences.

Community Watch

» Wauwatosa Common Council approves rezoning for Wisconsin Lutheran College parking structure 08:36 AM

» Student in custody for bringing knives to Wauwatosa East High School 3/3

» OSHA says drill rig involved in construction worker's death Updated:  3/3

» Twirly Birds vintage store plans return to Wauwatosa 3/2

» Dry cleaner seeks expansion into old City Market in Wauwatosa 3/2

» 'Momastery' author coming to Wauwatosa 2/27

» Wauwatosa's Folley and Reagan advance to state wrestling semis 2/26

» Wauwatosa East teacher Barb Bruesewitz named ProStart Teacher of the Year 2/26

» Pancake breakfast Sunday will raise money for scholarships 2/25

» Read the winning essays in Tosa's All-City Read contest 2/24

» Victim in fatal Wauwatosa house fire was 3-year-old girl Updated:  2/23

» MMSD commission OKs $6.4 million flood control project 2/23

» Medical examiner identifies 3-year-old who died in Wauwatosa house fire 2/22

» Menomonee flood plan would free part of stream from culvert 2/20

» Five idling cars stolen in one week in Wauwatosa 2/20

» Two men attempted to defraud two Apple stores with fake iPhones 2/20

» National German Exam qualifies some students for study abroad 2/20

» Personal finance students at Wauwatosa West guess value of items in "The Twelve Days of Christmas" 2/19

» Wauwatosa woman charged for armed robbery in Brookfield 2/19

» Men arrested for fighting at The Cheesecake Factory 2/19

» Tosa Skatepark brick sale ending Feb. 28 2/19

» Residents face off over proposed parking structure at Wisconsin Lutheran College 2/17

» Wauwatosa Alderman Wilke ousted from county supervisor race in primary 2/17

» Wauwatosa East High School students won Scholastic Art Awards 2/17

» Two Wauwatosa students won Scholastic Writing Awards 2/17

View All Posts Got a tip? Welcome rss

Advertisement

Advertisement

Hidden Tosa

 

"Hidden Tosa" is a semi-regular feature where reporter Rory Linnane explores the closed down and closed off parts of Wauwatosa.

2015 Writing Contest

 

(Click image for details)


Local Business Directory

CONNECT